Detalles de la búsqueda
1.
The impact of clinical symptoms and endoscopic and histologic disease activity on health-related quality of life in patients with ulcerative colitis following treatment with multimatrix mesalazine.
Qual Life Res
; 30(7): 1925-1938, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33651279
2.
Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis.
Dermatology
; 219(3): 209-18, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19657180
3.
Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study.
J Patient Rep Outcomes
; 2: 22, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30294708
4.
Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
Inflamm Bowel Dis
; 24(2): 450-463, 2018 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29361097
5.
Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
J Dermatolog Treat
; 18(6): 341-50, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18058494
6.
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Health Qual Life Outcomes
; 4: 71, 2006 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-17005043
Resultados
1 -
6
de 6
1
Próxima >
>>